Antissaliva Antibodies of Lutzomyia Longipalpis in area of Visceral Leishmaniasis

The aim of the present study was to assess the presence of antissaliva antibodies of Lutzomyia longipalpis in human hosts living in area of visceral leishmaniasis, located in the Center-West region of Brazil. The presence of antissaliva antibodies of L. longipalpis exhibited a strong correlation with the protection and development of antibodies against Leishmania sp. Of the 492 children studied, elevated antissaliva antibodies of L. longipalpis were detected in 38.4% of the participants. There was a higher percentage of positivity (64.7%) among children who exhibited anti-Leishmania sp. antibodies and among those who were positive in the delayed hypersensitivity test (34.8%).

[1]  K. Fukutani,et al.  Serological survey of Leishmaniainfection in blood donors in Salvador, Northeastern Brazil , 2014, BMC Infectious Diseases.

[2]  Mary E. Wilson,et al.  Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. , 2012, The American journal of tropical medicine and hygiene.

[3]  R. Lainson,et al.  A prospective study on the dynamics of the clinical and immunological evolution of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  J. Valenzuela,et al.  Using Recombinant Proteins from Lutzomyia longipalpis Saliva to Estimate Human Vector Exposure in Visceral Leishmaniasis Endemic Areas , 2010, PLoS neglected tropical diseases.

[5]  G. Romero,et al.  Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  C. Costa,et al.  Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  R. Titus,et al.  The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission , 2006, Parasite immunology.

[8]  Y. Belkaid,et al.  Toward a Defined Anti-Leishmania Vaccine Targeting Vector Antigens , 2001, The Journal of experimental medicine.

[9]  J. Ribeiro,et al.  Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? , 2000, The American journal of tropical medicine and hygiene.

[10]  J. Quaranta,et al.  Occurrence of Leishmania infantum Parasitemia in Asymptomatic Blood Donors Living in an Area of Endemicity in Southern France , 1999, Journal of Clinical Microbiology.

[11]  F. Simons,et al.  Cross-reactivity of skin and serum specific IgE responses and allergen analysis for three mosquito species with worldwide distribution. , 1997, The Journal of allergy and clinical immunology.